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Uptake and transcytosis of functionalized superparamagnetic iron 
oxide nanoparticles in an in vitro blood brain barrier model 
 
Angela Ivaska,b*, Emily H. Pilkingtonc, Thomas Blinc, Aleksandr Käkinenc, Heiki Vijab, Meeri 
Visnapuub,d, John F. Quinnc, Michael R. Whittakerc, Ruirui Qiaoc, Thomas P. Davisc,e, Pu Chun Kec* 
and Nicolas H. Voelckera,f-j* 
 
Two major hurdles in nanomedicine are the limited strategies for synthesizing stealth nanoparticles and poor efficacy of the 
nanoparticles in translocating across the blood brain barrier (BBB). Here we examined the uptake and transcytosis of iron 
oxide nanoparticles (IONPs) grafted with biomimetic phosphorylcholine (PC) brushes in an in vitro BBB model system, and 
compared it with bare, PEG or PC-PEG mixture grafted IONPs. Hyperspectral imaging indicated IONP co-localization with 
cells. Quantitative analysis with total reflection X-ray fluorescence spectrometry showed that after 24 h, 78% of PC grafted, 
68-69% of PEG or PC-PEG grafted, and 30% of bare IONPs were taken up by the BBB. Transcytosis of IONPs was time-
dependent and after 24 h, 16-17% of PC or PC-PEG mixture grafted IONPs had passed the model BBB, significantly more than 
PEG grafted or bare IONPs. These findings point to PC as a viable grafting strategy for the uptake and transcytosis of 
nanoparticles. 
Keywords: IONPs, in vitro BBB model, cellular internalization, transcytosis 
 
Introduction 
Superparamagnetic iron oxide nanoparticles (IONPs) represent a 
promising class of nanomaterials for biomedical applications owing 
to their biocompatibility, tuneable size and surface functionality, as 
well as flexibility in the control of their biodistribution and 
pharmacokinetics.1 Indeed, the physical properties of IONPs have 
been exploited for magnetic resonance imaging (MRI) and 
thermoablation therapy, while the ease of surface conjugation of 
IONPs is attractive for cell targeting. Unlike gadolinium- and iodine-
based MRI, X-ray and computed tomography agents that are cleared 
by kidneys to evoke toxicity, iron oxides are likely to enter the body’s 
iron cycle.2  
For better biocompatibility and prolonged blood circulation in 
biological systems, IONPs are usually coated or grafted with 
hydrophilic polymers such as polyethylene glycol (PEG).3-5 PEG, 
either in the linear or brushed form, resists protein adsorption by 
steric repulsion (for flexible PEG chains) or hydrogen bonding with 
water (for inflexible PEG chains).6,7 Consequently, PEGylation is the 
most common antifouling strategy against formation of the protein 
corona8,9 and in conferring a stealth effect to nanoconstructs in 
biomedical and biotechnological applications.7 However, despite its 
low toxicity, simple chemistry and commercial success, PEG is non-
biodegradable and may accumulate in vivo, and the potential effect 
from such accumulation is largely unknown.9 The recent proteomic 
identifications of the associations of PEGylated polymeric and gold 
NPs with apolipoproteins A-1 and E as well as complement proteins10-
12 highlight the potential immunological and pathological drawbacks 
of this major grafting strategy.  
Phosphorylcholine (PC), the hydrophilic polar head group of 
phospholipids has been considered as an alternative stealth 
material.13- 15 We have recently demonstrated a novel strategy of 
grafting IONPs with poly(2-(methacryloyloxy)ethyl 
phosphorylcholine) (poly(MPC)) brushes via a phosphonic acid 
linker.16 Coating of IONPs with poly(MPC) brushes afforded similar or 
enhanced stability, stealth effect,7 biocompatibility and cellular 
distribution compared with PEG coatings. To facilitate the continued 
development of alternative strategies for MRI applications, here we 
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characterized the uptake of IONPs grafted with poly(MPC) brushes16 
in cerebral endothelial cells, and transcytosis of those NPs through a 
model blood brain barrier (BBB)17, in comparison to PEG-grafted 
IONPs. The BBB regulates the transport of nutrients and 
biomolecules to the brain and is considered one of the most 
impermeable biological barriers. Therefore, efficient translocation of 
drugs and NPs through the BBB is a paramount challenge in 
nanomedicine and improvements in this aspect are of great 
importance.  
Materials and Methods 
Synthesis and characterizations of IONPs. IONPs synthesized and 
tested in the current study are shown in Fig. 1 and Table 1.  
Fig. 1. Schemes of IONPs grafted with brushed PC, PEG, as well as with 75:25 
and 50:50 brushed PC and PEG. 
 
Table 1. Description and characteristics of the IONPs  
 Surface characteristics Dh in 
water 
(nm) 
Dh in cell 
culture 
medium 
(nm) 
bare IONPs No surface 
functionalization 
323±9.8 c 340±16 d 
IONP-PEG poly(OEGA)  141±0.7 a 151±1.4 c 
IONP-PC poly(MPC) 121±0.7 a 112±2.0 c 
IONP PC:PEG 
75:25 
poly(OEGA) and 
poly(MPC)75:25 molar 
ratios 
105±0.6 a 103±0.3 a 
IONP PC:PEG 
50:50 
poly(OEGA) and 
poly(MPC)50:50 molar 
ratios 
112±1.1 a 126±2.5 a 
Dh – hydrodynamic diameter; a-polydispersity index (PDI) <0.2, b-PDI 0.2-0.3, 
c-PDI 0.3-0.4, d-PDI >0.4 
 
The detailed synthesis of IONPs coated with PC, PEG or PC-PEG 
mixtures is described in our recent publication.16 For transmission 
electron microscopy (TEM), 5 μL aliquot of 50 μg/mL IONPs was 
dropped onto copper grids (300 mesh, GCu300, ProSciTech), allowed 
to adsorb for 5 min and then air-dried. The samples were examined 
by TEM (JEOL JEM-2100F) at 200 kV. The hydrodynamic diameters 
(Dh) of the IONPs (10 μg/mL suspensions) were determined by 
dynamic light scattering (DLS) (Nano ZS, Malvern) in three parallels. 
Particle size distribution and polydispersity index (PDI) were analyzed 
using Malvern Zetasizer software.  
Cell culture. Human cerebral endothelial cell line hCMEC/D317 was 
from Cedarlane. This is an established cell line for modelling the BBB 
as it maintains a contact-inhibited monolayer, exhibits robust 
proliferation in response to endothelial growth factors, and grows 
indefinitely without phenotypic de-differentiation.17 This model 
system has been employed to study the transport of pathogens,18 
drugs19 and NPs20-23 through the BBB. hCMEC/D3 cells were grown at 
37° C with 5% CO2 on collagen I-coated cell culture flasks, membranes 
and coverslips (0.01% collagen I, Sigma, in 10 mM acetic acid for 30 
min). The cell growth and exposure medium was EBM-2 medium 
(Lonza) supplemented with 10 mM HEPES (Sigma), 1% penicillin-
streptomycin (Sigma), 5 μg/mL ascorbic acid (Sigma), 1.4 μM 
hydrocortisone (Sigma), 5% FBS (Hyclone), 1% chemically defined 
lipid concentrate (Gibco), and 1 ng/mL basic fibroblast growth factor 
(Sigma). The cells were kept at a passage number between 25 and 35 
and the cell density on culture dishes between 2×105 and 1×106 
cells/mL. 
Neutral red uptake assay for cytotoxicity. A neutral red in vitro 
toxicology assay kit (Sigma) was used to determine IONP-induced 
cytotoxicity. hCMEC/D3 (seeded at 5×104 cells/mL) were exposed to 
0.002-1 pM (0.5-100 μg/mL) IONPs/mL on 96-well plates and the 
assay was carried out per Sigma protocol (see Supporting 
Information or SI).  
Laurdan assay for cell membrane fluidity. The assay was carried out 
according to Owen et al. 24 5×105 hCMEC/D3 cells/mL were seeded 
to collagen I-coated 0.17 μm coverslips (Zeiss), allowed to attach 
over 24 h, and exposed to 50 μg/mL (~0.5 pM) IONPs for 24 h. After 
that 5 μM Laurdan dye (6-lauryl-2-dimethylamino-napthalene) 
diluted in cell culture medium was added and cells were incubated 
for 30 min at 37° C and 5% CO2. Coverslips with cells were mounted 
using Fluoro Gel with DABCO on microscope slides and imaged with 
confocal fluorescence microscopy (Elyra, Zeiss) using 405 nm/430-
470 nm or 480-550 nm for gel/liquid ordered membrane channel and 
liquid disordered membrane channel, respectively. The images were 
saved as 64-bit TIFF and the generalized polarization (GP) values of 
the membrane pixels were calculated25 (see SI). 
Hyperspectral imaging of IONP-exposed cells. hCMEC/D3 cells were 
grown on coverslips and exposed to 50 μg/mL (~0.5 pM) IONPs as 
above. After exposure, the growth medium was discarded, the cells 
were washed with PBS and fixed with 4% formaldehyde solution 
(Sigma) for 10 min. The coverslips were mounted on microscope 
slides and the cells were imaged by a dark-field hyperspectral 
microscope (CytoViva). ENVI 4.8 (CytoViva) was used for data 
analysis and identification of IONPs in cells16 (see SI).  
Growing and imaging cells on transwell membranes. 2×105 
hCMEC/D3 cells/mL were seeded to collagen I-treated transwell 
permeable supports (Corning, 6.5 mm diameter) with 3.0 μm pore 
size membranes that were placed into 24-well plates. The cells were 
allowed to grow for 13 d and the transepithelial electrical resistance 
(TEER) was measured daily or every 2 d using a Millicell® ERS-2 
Voltohmmeter (Merck Millipore). The TEER value of the medium was 
registered and subtracted as the background from the values 
measured in cell-containing transwell inserts. For staining, the 6 d 
grown cells on transwell membranes were rinsed with PBS and fixed 
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with 4% formaldehyde for 10 min, rinsed with PBS and incubated 
with 0.1% Triton X-100 for 5 min. Then the cells were incubated with 
0.16 μM rhodamine (TRITC) phalloidin (ThermoFisher) in PBS for 20 
min and 0.2 μg/mL Hoechst 33342 (ThermoFisher) in PBS for 10 min. 
Images were taken using confocal fluorescence microscopy (Zeiss 
Elyra, 405, 488 and 530 nm) with a 63× water-immersion objective. 
3D images were constructed from z-stacks of 0.4 µm between 
individual layers. 
Imaging IONP exposed cells using transmission electron 
microscopy. hCMEC/D3 monolayers grown on transwell membrane 
as above and exposed to 50 μg/mL of the different versions of IONPs 
for 24 h were prepared for TEM using a modified protocol from 
Schrand et al.26 Detailed sample descriptions are given in the SI. 
Ultrathin sections were prepared by Leica EM UC7 and the sections 
were viewed using Tecnai G2 Spirit BioTwin at 120 kV. 
Translocation of IONPs through hCMEC/D3 cell monolayer. 6-d 
confluent layers of hCMEC/D3 cells on transwell membranes were 
exposed to 50 μg/mL (~0.5 pM) of the different versions of IONPs. 
180 μL of IONPs suspended in cell culture medium was added to the 
apical side (mimicking the bloodstream, i.e., luminal side) of the 
transwell system and 700 μL of cell culture medium (without IONPs) 
was pipetted to the lower, basolateral layer (eventually, brain side, 
i.e., abluminal side). The cells were incubated for 1, 4 or 24 h after 
which samples from the apical (blood side) and basolateral (brain 
side) layers were collected. Next, the cell monolayer on the 
membranes was removed by adding 100 μL trypsin-EDTA (Sigma), 
incubating for 15 min at 37° C, addition of 100 μL of cell culture 
medium followed with resuspension. 7% HNO3 was added to all 
collected samples. In addition, the membranes were cut out and 
exposed to 7% HNO3 overnight to remove membrane-bound residual 
IONPs. In parallel to transwell membranes with cell monolayers, we 
also determined the translocation of IONPs through transwell 
membranes lacking a cell monolayer. In this case, only samples from 
the apical and basolaterial layers were collected and membrane-
bound IONPs were collected. The Fe concentration in the samples 
was analyzed using total reflection X-ray fluorescence (TXRF) (Picofox 
S2, Bruker) as described in reference 16. Briefly, the collected 
samples were sonicated (Branson Model 450 with a microtip, 5% 
power) for 10 s, 40 μL of each sample was mixed with 40 μL of the 
reference element (Ga, at 2 mg/L in 1% HNO3) and 3 μL of the sample 
was pipetted into a quartz sample holder (Analyslide Petri Dish, Pall). 
The sample was dried at 60° C and fluorescence was measured for 
600 s. Fe concentration was calculated according to the Ga standard. 
Cell media without IONPs were used to determine the media 
background at 0.29±0.03 μg/mL of Fe. All results from IONP 
exposures were significantly (p < 0.05) higher than the media 
background.  
Replicates and statistical analysis. At least 3 independent replicates 
were performed for each sample condition. IONP translocation was 
analyzed using one-way ANOVA: Post Hoc Multiple Comparisons 
(Tukey) in SPSS software (IBM). p < 0.05 (i.e., 95%) differences 
between different treatments were considered as statistically 
significant.  
Results 
Characterization of IONPs. TEM images and hydrodynamic size of 
the five types of IONPs with different surface functionalities (Table 1) 
are shown in Fig. 2. The primary size of all the IONPs variants was ~15 
nm. Overall, the dispersibility of all samples was good with a 
polydispersity index<0.4 (Table 1) in water and slightly above 0.4 in 
cell culture medium. Although the IONP cores were identical, the Dh 
of the IONPs varied. Specifically, bare IONPs possessed the largest 
average hydrodynamic size, 323 nm in water and 340 nm in cell 
culture medium, and PC, PEG and PC:PEG mixture coated IONPs 
exhibited significantly lower average Dh values (between 102 and 
151 and 250 nm) and thus, better suspension stability (Fig. 2). 
Fig. 2. TEM images of (A) bare IONPs, (B) IONP-PEG, (C) IONP-PC, (D) IONP-PC:PEG 75:25 and (E) IONP-PC:PEG 50:50. The scale bar in (A) applies to all panels. 
The insets show the hydrodynamic diameter (Dh) of IONPs in cell culture medium. Average Dh values with standard deviations are shown.
Cytotoxicity of IONPs to human cerebral endothelial cells. To keep 
the integrity of hCMEC/D3 BBB model during nanoparticle 
incubation, the toxicities of the IONPs with different surface capping 
agents were evaluated. As shown in Fig. 3A no significant loss in 
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cellular viability was observed for exposures up to 1 pM (100 μg/mL) 
(Fig. 3A). Therefore, 0.5 pM (50 μg/mL) – a concentration of IONPs 
not affecting cellular viability, was chosen for further studies on 
cellular uptake and BBB transport.  
In addition to cytotoxicity, the effect of IONP exposure on cell 
membrane fluidity was evaluated. Laurdan, a dye which upon an 
increase in membrane fluidity, undergoes a spectral redshift 24 was 
employed as a reporter dye for temporary changes in the 
membranes of 0.5 pM IONP exposed cells. Compared to non-
exposed cells, IONP-exposed hCMEC/D3 cells exhibited increased 
generalized polarization values indicating a relatively high fraction of 
ordered bilayer membrane (Fig. 3B). Thus, exposure of cells to IONPs, 
most notably for IONP-PC and least for bare IONPs, induced a 
significant reduction in membrane fluidity compared to non-exposed 
cells. 
 
 
Fig. 3. (A) Cytotoxicity of IONPs to hCMEC/D3 cells over 24 h, measured with neutral red uptake assay; non-exposed cells were considered 100% viable. Down 
pointing arrows indicate 50 µg/mL (~0.5 pM) concentration that was used in cellular uptake and BBB translocation tests. (B) Membrane fluidity of cells 
exposed to 50 μg/mL IONPs for 24 h, showing representative fluorescence images of ordered and disordered membrane channels and their generalized 
polarization (GP) values. Increases in GP indicate decreased membrane fluidity. 
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The interactions between IONPs and hCMEC/D3 cells were further 
examined using dark field and hyperspectral imaging (Fig. 4). Upon 
24-h exposure to 0.5 pM IONPs, all IONP types were co-localized with 
the cells (NPs shown as bright pixels in Fig. 4A-E). The peak scattering 
wavelengths of the cell-associated aggregates were between 450 
and 650 nm (Fig. 4F), close to the absorbance spectrum of IONPs. 
Collectively, these experiments verified cellular interactions and 
potential uptake of the IONPs by the BBB model cells.  
 
Fig. 4. Cells exposed to 50 g/mL of (A) bare IONPs, (B) IONP-PEG, (C) IONP-PC, (D) IONP-PC:PEG 75:25 and (E) IONP-PC:PEG 50:50. For each image, background 
(of non-exposed cells) was subtracted and one cell shown inside a square was selected to identify the characteristic spectra of IONPs (selected pixels shown 
in red). The characteristic reflectance spectra are shown in insets of A-E and combined in panel F. The presence of the characteristic spectra in the rest of the 
images was identified (colored pixels in A-E). 
 
Translocation of IONPs across a model BBB. Ta quantitatively assess 
the cellular uptake and translocation of IONPs in BBB model, 
hCMEC/D3 cerebral endothelial cells were grown on 3 μm transwell 
membranes to confluent layer and exposed to 0.5 pM (50 µg/mL) of 
each IONP. In order to monitor the integrity of the in vitro BBB before 
the test with NPs, cell growth and monolayer formation on transwell 
membranes were examined using TEER measurement and 
microscopy. The TEER measurement showed an increased electrical 
resistance up to 60 Ω/cm2 at day 6, after which no significant increase 
in resistance was observed (Fig. S1A). Therefore, 6 d was selected as 
an optimal time for cell monolayer formation on the transwell 
system. Visual representation of a 6-d cell monolayer on membranes 
is given in Fig. S1B-D, and the presence of mature tight junctions (TJ) 
in cell monolayer (vascular endothelial cadherin, one of the TJ 
components) is shown in Fig. S2C.  
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Fig. 5. Localization of IONPs in hCMEC/D3 cell layer on transwell membrane under TEM. The cell monolayer on transwell membranes was exposed to 50 
µg/mL IONPs. Selected images show an early endocytotic vesicle in (A) IONP-PC:PEG 75:25 exposed cells, (B) a late endocytotic vesicle in IONP-PC:PEG 50:50 
exposed cells and (C) exocytotic vesicle on the basolateral side of IONP-PEG exposed cells. Insets I and II in each panel are enlarged views of regions indicated 
with dashed lines. Images of cells exposed to all variants of IONPs are shown in Fig. S3.  
Prior to quantitative analysis of IONP translocation, intracellular 
localization and trafficking of IONPs through the cell layer was 
imaged with TEM. For all IONP exposures, NPs were observed in 
endocytotic vesicles in hCMEC/D3 cells (Fig. S3) and the presence of 
Fe in the vesicles was proven with energy dispersive X-ray (EDX) 
analysis (Fig. S3D). Fig. 5A-C show representative images of NPs 
taken up by the cells to endocytotic vesicles from the apical side, NPs 
in a vesicular structure inside the cells and NPs exocytosed by the 
cells to the basolateral side of the cell layer. For quantitative analysis 
of cellular translocation of IONPs in the in vitro BBB model, the Fe 
content was quantified on apical, basolateral and cell layers using 
TXRF. To first characterize the kinetics of BBB translocation, the 
fractions of IONP-PEG in the apical, basolateral sides and cell 
monolayer after 1, 4 and 24 h of exposure were analyzed (Fig. 6B). 
One hour of exposure was enough for 13% of the added NPs to 
associate with the monolayer and 0.17% of the added NPs to 
translocate through the BBB model. After 4 h, 22% of the added NPs 
were associated with BBB and 3.5% of the added NPs translocated 
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across the barrier, and after 24 h, 68% of the particles were 
associated with the cells and 15% passed the cell layer. In 
comparison, for transwell membranes lacking the cell monolayer, 
the maximum translocation of IONP-PEG was achieved within 4 h 
(Fig. S4).  
In 24 h nanoparticle exposed cells, clear differences in quantities of 
Fe in the studied layers were observed for IONPs with different 
surface functionalities (Fig. 6). The most significant difference 
between the different IONPs was their partitioning in the hCMEC/D3 
cell monolayer, i.e., 30% of bare IONPs, 68% of IONP-PEG, 69% of 
IONP-PC:PEG 75:25 and IONP PC:PEG 50:50 and 78% of IONP-PC 
were co-localized with the cells, respectively (Fig. 6E). This is a strong 
indication of better association of functionalized IONPs compared to 
bare IONPs with the model BBB. These data also show that PC surface 
functionality enabled significantly better cellular contact and uptake 
compared with PEG surface coating (Fig. 6).  
Fig. 6. Transport of IONPs in transwell system with hCMEC/D3 cell layer. (A) 
Schematic representation of the transwell system. A 6 d grown cell monolayer 
on the transwell membrane was exposed to 50 g/mL of the different types 
of IONPs that were introduced from apical side; Fe concentrations in apical 
and basolateral sides, in cell layer, and in membrane were quantified using 
TXRF. (B) Time-dependent localization of IONP-PEG in different 
compartments of the transwell system. Localization of IONPs with different 
coatings in (C) apical and (D) basolateral side, (E) cell monolayer or (F) on the 
membrane after 24 h exposure. Means and standard deviations of three 
independent experiments are shown, a – significant (p < 0.05) difference 
between IONPs and IONPs with PEG, PC coatings, or mixture coatings; b - 
significant (p < 0.05) difference between IONP-PEG and IONP-PC, IONP-
PC:PEG 75:25 or IONP-PC:PEG 50:50. In panels C-F the percentages of 
introduced IONPs are shown. 
We acknowledge that the fraction of IONPs that was co-localized 
with the cell monolayer could include both cell-membrane-
associated NPs as well as those endocytosed by the cells. But since 
the cell monolayer was carefully rinsed before its digestion and the 
IONPs were visualized inside the cells after 24-h exposure most of 
the cell-associated NPs were likely localized inside the hCMEC/D3 
cells. 
TXRF analysis of the Fe concentration in the basolateral layer of the 
BBB model, i.e., the side representing the brain, showed that IONP-
PC and IONP-PC:PEG 75:25 transcytosed through the model BBB 
significantly (p < 0.05) more efficiently than bare IONPs (Fig. 6D). In 
the case of bare IONPs, 13% of the added NPs were detected in the 
basolateral layer whereas in the case of IONP-PC and IONP-PC:PEG 
75:25 17% of the NPs were transported to the basolateral side (Fig. 
6D). Transcytosis of IONP-PEG and IONP-PC:PEG 50:50 was 15 and 
16%, respectively and did not statistically differ from that of bare 
IONPs. Thus, there was a notable improvement in transcytosis for PC-
functionalized particles compared with PEG-coated ones.  
Discussion 
This study aimed to characterize the cellular uptake and 
translocation of IONPs with different surface grafting agents (Table 
1; Fig. 1) with an in vitro hCMEC/D3 BBB model. All the tested IONPs 
proved non-toxic up to 100 µg/mL to the BBB model, consistent with 
previous observation with human embryonic kidney cells.16 IONP-
exposed cells (Fig. 3) showed increased membrane ordering 
(decreased fluidity), following the sequence of bare IONPs, IONP-
PEG, IONP-PC:PEG 50:50, IONP-PC:PEG 75:25, and IONP-PC. 
Decreased membrane fluidity upon NP exposure has been reported 
in previous studies.27 Using computer simulations, Mhashal and 
Roy28 also showed that gold NPs coming into contact with or 
penetrating into a lipid bilayer gave rise to local membrane 
deformations and enhanced local lipid ordering, thereby decreasing 
the bilayer fluidity. We therefore infer that the increasing ordering in 
IONP-exposed cell membranes was an indicator of cellular binding or 
uptake of the IONPs. Co-localization of IONPs with cells was validated 
by hyperspectral imaging (Fig. 4). 
To enable the major application of IONPs as MRI contrast agents in 
brain imaging, we analyzed the potential of IONPs to translocate 
through a model in vitro BBB – a monolayer of hCMEC/D3 cerebral 
endothelial cells grown for 6 d on 3 μm pore size membranes on 
transwell plates (Fig. S1B-D). Pore size of 3 μm was selected since 
earlier studies indicated blockage of smaller (0.4 μm) pores by 50 nm 
SiO2 NPs.23 The 3 μm pore size membranes (empty membranes with 
no cells) allowed the transloaction of ~50% of the IONPs (IONP-PEG 
were used as an example) through the membranes within 4 h, and 
only a slight increase up to 55% was observed when exposure was 
prolonged to 24 h (Fig. S4B). Thus, after at least 4 h, the IONP 
concentrations on both slides of the membrane were equalized and 
the NPs were moving freely in the empty transwell system.  
The integrity of 6 d hCMEC/D3 cell monolayer on transwell 
membranes was assured by TEER, which showed an electrical 
resistance of 60 Ω/cm2 (Fig. S1A), an improvement over the 
previously reported values of 30-50 Ω/cm. 17 While this TEER value is 
relatively low compared to what could be expected in vivo17, and 
certain imperfections (areas with bi-or multilayers of cells, holes or 
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gaps may remain on the membranes22) cannot be excluded, the 
transwell set-up has been used in a number of studies20-23 and is a 
well-established method.23 We stained the 6 d hCMEC/D3 cell 
monolayer with vascular endothelial cadherin (one of the TJ 
components) antibody and subsequent fluorescent staining 
indicated that TJs had formed over most of the observed area (Fig. 
S2C). The latter proved the integrity of the 6-d grown BBB model.  
When the model BBB system was exposed to IONPs for 24 h and cells 
were observed by electron microscopy, IONPs were observed in 
endocytotic vesicles in all exposures (Fig. S3). Transcytosis was also 
observed as shown in Fig. 5. As proven by EDX analysis, particulates 
observed in endocytotic vesicles contained Fe (Fig. S3D).  
It is interesting to note that there are only a few studies available 
where translocation of NPs through BBB has been quantitatively 
studied,20,22,23,29 and all these studies relied on measuring the 
fluorescence of specifically tagged NPs. Here the transcytosis efficacy 
of IONPs was quantified with TXRF. We observed that the transport 
of IONPs in the BBB model differed between the different types of 
IONPs. Bare IONPs had clearly lower presence in the cell layer and 
basolateral (brain side) layer than the surface-coated IONPs, while 
higher concentration of bare IONPs was present in apical (blood side) 
layer. Among different coatings, PC-coated IONPs were clearly 
present at the highest concentrations in the cell layer (78%) and the 
basolateral layer (17%) (Fig. 6D and E). Thus, PC may be as an 
alternative and improved grafting strategy for the optimal BBB 
transport of IONPs. While our transcytosis efficacy of IONPs ranged 
from 13 to 17%, Thomsen et al.30 showed that transcytosis of 118 nm 
uncoated IONPs was ~6% (3-4 µg/mL IONPs transported at 60 µg/mL 
exposure concentraion), Bramini et al.22 demonstrated that 24 h 
exposure of a model BBB resulted in the passage of ~7% of carboxy-
modified polystyrene particles and Georgieva et al.21 showed that, 
depending on surface properties, 2-10% of SiO2 NPs translocated 
through the cell layer. This latter study also reported that 60-90% of 
differently coated SiO2 NPs remained bound with the BBB cell layer – 
a value that is similar to our measurement for surface functionalized 
IONPs (Fig. 6E).  
Although the uptake and transcytosis of NPs in BBB model systems 
has been examined by several studies, the mechanisms behind those 
processes remain somewhat unclear. Ye et al.29 studied the uptake, 
accumulation and transcytosis of SiO2, TiO2 and Au NPs through the 
layers of hCMEC/D3 and found that the NPs in general accumulated 
in cells via the endo-lysosomal pathway. Georgieva et al.21 
demonstrated that endocytosis of NPs by BBB cells depended on 
particle surface coating and the main pathways were caveolae-
mediated endocytosis and micropinocytosis. Exposure of BBB layers 
to NPs (SiO2 and quantum dots) caused loss of TJs between the cells 
and thinning of the cell layer,20 which could be an additional 
mechanism enabling translocation of NPs through the endothelial 
cell layer. One of the translocation pathways that NPs are likely to 
use in BBB could be adsorptive-mediated transcytosis which takes 
place via clathrin-mediated vesicles or caveolae.31, 32 This 
transcellular transport mechanism may start by random uptake of 
molecules (or particles) in luminal space or specific interaction of the 
molecules with negatively charged clathrin-coated pits near the 
membrane of endothelial cells. 31 It should be however mentioned 
that the transcytosis efficacy of BBB is orders of magnitude lower 
compared to any other endothelial layer32 which suggests that the 
fraction of transcytosed NPs can be relatively low. Hanada et al.20 
calculated the translocation efficacy of NPs through their model BBB 
and found it to depend greatly on particle concentration. For 
example, permeability coefficient (Papp) for 30 nm SiO2 NPs varied 
from 1×10-6 cm/s to 4×10-6 cm/s depending on whether the BBB 
monolayer was exposed to 100-500 μg or 1,000 μg NPs/mL. Our 
calculations showed that the permeability coefficient for 50 μg/mL 
of IONP-PC in the transwell system with hCMEC/D3 cell layer in our 
study was 4×10-6 cm/s. Although the increase in transcytosis efficacy 
of IONP-PC particles compared to IONP-PEG was relatively small, we 
find IONP surface grafting with PC a viable strategy to design 
biocompatible NPs with enhanced cellular uptake properties. 
Conclusions 
We have examined cellular uptake and transcytosis of IONPs with an 
in vitro human BBB model employing a combination of fluorescence 
imaging, electrical measurement, and total reflection X-ray 
fluorescence. The uptake and transcytosis efficacies of IONP variants 
differed being dependent on surface grafting agent. This study 
demonstrated that, in comparison with uncoated and PEGylated 
IONPs, grafting of IONPs with PC brushes is a viable strategy affording 
comparable biocompatibility, enhanced stability, cellular uptake and 
improved transcytosis – all these features are desirable for MRI 
imaging and drug delivery and can be attributed to the natural 
affinity of PC – the head group of phosphatidylcholine – for the 
lipophilic membrane environment, plus the biomimetic property of 
PC. Future in vivo studies will be conducted to examine the 
biocompatibility and cellular uptake of PC-grafted IONPs.  
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